Safety and Effectiveness of New COVID Bivalent Boosters Based on a Study of Eight Mice?
With no safety and efficacy evidence from human clinical trials, on Aug. 31, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUAs) for Pfizer/BioNTech’s Comirnaty and Moderna/NIAID’s Spikevax messenger RNA (mRNA) COVID-19 biologics to distribute “bivalent formulations” (two-in-one) of the shots to use as a “single booster dose.”1 2 The […]
COVID Vaccination May Impair Innate Immune Function
Epidemiologist and researcher, Paul Alexander, PhD warns that COVID-19 vaccination could permanently damage the innate immune system in children and prevent it from functioning and developing normally.1 The innate (cellular) immune system acts as the first line of defense against the challenge of pathogens causing infectious disease. When the innate immune system identifies pathogenic viruses, […]
Guillain-Barré Syndrome Linked to COVID-19 Shots
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]
Myocarditis Risk Following mRNA COVID Shots May Be Far Higher Than Previously Estimated
A new study conducted by researchers from the U.S. Centers for Disease Control and Prevention (CDC) and several universities and hospitals in the United States shows that the risk of myocarditis (inflammation of the heart muscle) after receiving a messenger RNA (mRNA) COVID-19 biologic is 133 times greater than the normal risk for the condition […]
Texas Gov. Abbott Joins Growing Club of Coronavirus “Breakthrough Cases”
Opinion | It is interesting to observe the mainstream media’s reporting of the recent news that Governor Greg Abbott of Texas has tested positive for the SARS-CoV-2 virus. For example, the headline of an article by CNBC reads, “Texas Gov. Abbott, who banned mask and vaccine mandates, tests positive for Covid.” Another headline by Yahoo! News reads, “Texas […]
Many Americans Worry About the Safety of COVID Biologics
A new poll conducted Yahoo! News/YouGov during July 13-15, 2021 found that 37 percent of unvaccinated Americans are more fearful of the three experimental COVID-19 biologics currently available in the United States than they are of the SARS-CoV-2 virus that can cause the disease. The survey of 1,715 adults in the U.S. found that only […]
Woman Dies Minutes After Getting COVID-19 Vaccine at Cal Poly Pomona
A 78-year-old woman died on Feb. 12, 2021 after receiving the first dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 vaccine for COVID-19 in California. The woman, whose name has not been released to the public, was given the injection at around 12:00 pm at a COVID-19 vaccination site at California State Polytechnic (Cal Poly) […]
CDC Reports 1,637 Deaths Following COVID-19 Vaccinations
The Centers for Disease Control and Prevention (CDC) told The Epoch Times in an e-mail that as of Mar. 8, 2021 over 92 million doses of mRNA vaccines for COVID-19 have been injected, with 1,637 deaths occurring following the injections. The CDC claims the vaccines are safe, but a comparison between the rates of deaths […]
Over 3,000 “Health Impact Events” After COVID-19 mRNA Vaccinations
Between Dec. 11 and 18, 2020, the U.S. Food and Drug Administration (FDA) granted Pfizer/BioNTech and Moderna pharmaceutical companies an Emergency Use Authorization (EUA)1 to distribute COVID-19 vaccines using messenger RNA (mRNA) technology that to date has not been licensed for use in humans.2 3 4 5 Although the Advisory Committee on Immunization Practices (ACIP) […]
Pfizer/BioNTech’s COVID-19 Vaccine Causes Adverse Reactions in Over Half of Clinical Trial Volunteers
In clinical trials of the experimental messenger RNA (ribonucleic acid) COVID-19 vaccine (BNT162b1), which is being developed by Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany, adverse reactions have occurred in more than 50 percent of the adult participants. The Phase 1/2 human trials of BNT162b1 vaccine, which were conducted May-June 2020, […]
